ArticlePlastic and reconstructive surgery. Global open2025
Exploring Breast Reconstruction in Late-stage Breast Cancer Patients.
Article in Plastic and reconstructive surgery. Global open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Breast reconstruction after mastectomy improves quality of life for breast cancer patients. As more late-stage patients undergo reconstruction, it is essential to understand how treatment regimens and radiation impact outcomes. This study compared early- and late-stage breast cancer patients, examining comorbidities, reconstructive details, complications, and satisfaction. Methods: A total of 989 patients (903 early-stage; 86 late-stage) who underwent breast reconstruction between January 2011 and February 2025 were reviewed. Cancer staging followed the National Cancer Institute definitions: early-stage (I-IIIA) and late-stage (IIIB-IV). Results: Late-stage patients had higher rates of diabetes ( Conclusions: Breast reconstruction is feasible and safe in late-stage breast cancer patients. Despite greater comorbidities and more aggressive disease, late-stage patients achieve complication rates and satisfaction comparable to early-stage patients. Future research should refine protocols to address the specific needs of late-stage patients, emphasizing quality of life and patient-centered outcomes.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.